A1029350
1,2-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene , ≥97% , 612847-09-3
Synonym(s):
1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one, Akti-1/2;Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem
CAS NO.：612847-09-3
Empirical Formula: C34H29N7O
Molecular Weight: 551.64
MDL number: MFCD09026909
EINECS: 1592732-453-0
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB249.60 | In Stock |
|
| 25mg | RMB751.20 | In Stock |
|
| 100mg | RMB2960.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 242-245°C (dec.) |
| Density | 1.350±0.06 g/cm3(Predicted) |
| storage temp. | Refrigerator |
| solubility | insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL in DMSO |
| pka | 7.49±0.50(Predicted) |
| form | Yellow solid |
| color | White to Yellow to Orange |
| CAS DataBase Reference | 612847-09-3 |
Description and Uses
AKTI-1/2 is a Allosteric Akt (PKB) inhibitors used in synergistic combination therapy for the treatment of cancer.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
